Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 2
2007 2
2008 1
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

3 results
Results by year
Filters applied: . Clear all
Page 1
Metabolic therapy for patients with diabetes mellitus and coronary artery disease.
Rosano GM, Vitale C, Fragasso G. Rosano GM, et al. Am J Cardiol. 2006 Sep 4;98(5A):14J-18J. doi: 10.1016/j.amjcard.2006.07.004. Epub 2006 Jul 24. Am J Cardiol. 2006. PMID: 16931201 Review.
Therefore, in patients with diabetes and CAD, the ischemic metabolic changes are heightened by the metabolic changes in patients with diabetes. ...Thus, modulation of myocardial FFA metabolism should be the key target for metabo
Therefore, in patients with diabetes and CAD, the ischemic metabolic changes are heightened by the metabolic cha …
Effect of free fatty acid inhibition on silent and symptomatic myocardial ischemia in diabetic patients with coronary artery disease.
Marazzi G, Wajngarten M, Vitale C, Patrizi R, Pelliccia F, Gebara O, Pierri H, Ramires JA, Volterrani M, Fini M, Rosano GM. Marazzi G, et al. Int J Cardiol. 2007 Aug 9;120(1):79-84. doi: 10.1016/j.ijcard.2006.08.082. Epub 2006 Nov 28. Int J Cardiol. 2007. PMID: 17134770 Clinical Trial.
OBJECTIVE: Free fatty acid inhibition with trimetazidine (TMZ) improves myocardial metabolism and myocardial ischemia in patients with coronary artery disease (CAD). ...Aim of the present study was to evaluate whether the metabolic effect …
OBJECTIVE: Free fatty acid inhibition with trimetazidine (TMZ) improves myocardial metabolism and myocardial isc …
Metabolic agents in the management of diabetic coronary patients: a new era.
Celik T, Kursaklioglu H, Iyisoy A, Jata B. Celik T, et al. Int J Cardiol. 2008 Jun 23;127(1):133-4. doi: 10.1016/j.ijcard.2007.04.018. Epub 2007 Jun 11. Int J Cardiol. 2008. PMID: 17561287
Modulation of myocardial free fatty acid metabolism is the key target for metabolic interventions in patients with coronary artery disease (CAD) with diabetes mellitus (DM). Because of its beneficial effects on heart metabolism at …
Modulation of myocardial free fatty acid metabolism is the key target for metabolic interventions in patients with coro …